These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3971358)
1. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts. Shewach DS; Daddona PE; Ashcraft E; Mitchell BS Cancer Res; 1985 Mar; 45(3):1008-14. PubMed ID: 3971358 [TBL] [Abstract][Full Text] [Related]
2. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. Verhoef V; Fridland A Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098 [TBL] [Abstract][Full Text] [Related]
3. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells. Shewach DS; Mitchell BS Cancer Res; 1989 Dec; 49(23):6498-502. PubMed ID: 2819707 [TBL] [Abstract][Full Text] [Related]
4. Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. Owens JK; Shewach DS; Ullman B; Mitchell BS Cancer Res; 1992 May; 52(9):2389-93. PubMed ID: 1568208 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological and biochemical strategies to increase the accumulation of arabinofuranosylguanine triphosphatein primary human leukemia cells. Rodriguez CO; Legha JK; Estey E; Keating MJ; Gandhi V Clin Cancer Res; 1997 Nov; 3(11):2107-13. PubMed ID: 9815603 [TBL] [Abstract][Full Text] [Related]
6. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx. Prus KL; Averett DR; Zimmerman TP Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735 [TBL] [Abstract][Full Text] [Related]
7. A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells. Yamauchi T; Nishi R; Kitazumi K; Nakano T; Ueda T Oncol Rep; 2010 Feb; 23(2):499-504. PubMed ID: 20043113 [TBL] [Abstract][Full Text] [Related]
8. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine. Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60. Grant S; Bhalla K; Rauscher F; Cadman E Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943 [TBL] [Abstract][Full Text] [Related]
10. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity. Lotfi K; MÃ¥nsson E; Peterson C; Eriksson S; Albertioni F Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684 [TBL] [Abstract][Full Text] [Related]
11. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells. Sidi Y; Hudson JL; Mitchell BS Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392 [TBL] [Abstract][Full Text] [Related]
12. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity. Abe I; Saito S; Hori K; Suzuki M; Sato H Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175 [TBL] [Abstract][Full Text] [Related]
13. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity. Fridland A Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707 [TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine. Bhalla K; Nayak R; Grant S Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4). Townsend A; Leclerc JM; Dutschman G; Cooney D; Cheng YC Cancer Res; 1985 Aug; 45(8):3522-8. PubMed ID: 2410096 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and selectivity of arabinonucleoside in human lymphoid cells. Fridland A; Verhoef V Proc Soc Exp Biol Med; 1985 Sep; 179(4):456-62. PubMed ID: 2991939 [TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines. Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202 [TBL] [Abstract][Full Text] [Related]
19. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase. Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920 [TBL] [Abstract][Full Text] [Related]
20. Dual mechanisms of 9-beta-D-arabinofuranosylguanine resistance in CEM T-lymphoblast leukemia cells. Curbo S; Zhu C; Johansson M; Balzarini J; Karlsson A Biochem Biophys Res Commun; 2001 Jul; 285(1):40-5. PubMed ID: 11437369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]